Repare Therapeutics Ownership | Who Owns Repare Therapeutics?

Repare Therapeutics Ownership Summary

Repare Therapeutics is owned by 64.66% institutional investors, 1.25% insiders, and 34.10% retail investors. Bvf inc/il is the largest institutional shareholder, holding 24.08% of RPTX shares. ARK Genomic Revolution ETF is the top mutual fund, with 2.65% of its assets in Repare Therapeutics shares.

RPTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Repare Therapeutics	64.66%	1.25%	34.10%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bvf inc/il	10.33M	24.08%	$14.36M
Blue owl capital lp	3.44M	8.02%	$4.79M
Orbimed advisors	3.32M	7.74%	$4.62M
Versant venture management	2.65M	6.17%	$3.68M
Redmile group	1.59M	3.70%	$2.20M
Aquilo capital management	1.29M	3.05%	$1.69M
Mpm asset management	1.12M	2.61%	$1.56M
Bioimpact capital	819.92K	1.91%	$1.14M
Acadian asset management	681.18K	1.59%	$942.00K
Renaissance	347.46K	0.82%	$455.17K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Versant venture management	2.65M	4.48%	$3.68M
Mpm asset management	1.12M	3.60%	$1.56M
Aquilo capital management	1.29M	2.56%	$1.69M
Blue owl capital lp	3.44M	1.54%	$4.79M
Bvf inc/il	10.33M	0.51%	$14.36M
Redmile group	1.59M	0.23%	$2.20M
Bioimpact capital	819.92K	0.20%	$1.14M
Orbimed advisors	3.32M	0.12%	$4.62M
Militia capital partners, lp	119.18K	0.08%	$165.66K
Affinity asset advisors	200.00K	0.04%	$278.00K

Top Buyers

Holder	Shares	% Assets	Change
Aquilo capital management	1.29M	2.56%	304.35K
Militia capital partners, lp	119.18K	0.08%	119.18K
Jpmorgan chase	85.80K	-	85.80K
Blackrock	141.80K	-	80.54K
Millennium management	170.96K	0.00%	67.64K

Top Sellers

Holder	Shares	% Assets	Change
Ark investment management	-	-	-1.12M
Deep track capital, lp	-	-	-904.26K
Artal group	-	-	-700.00K
Ensign peak advisors	-	-	-344.33K
Redmile group	1.59M	0.23%	-298.21K

New Positions

Holder	Shares	% Assets	Change	Value
Militia capital partners, lp	119.18K	0.08%	119.18K	$165.66K
Xtx topco	43.17K	0.00%	43.17K	$60.01K
Quinn opportunity partners	40.00K	0.00%	40.00K	$55.60K
Newedge wealth	32.96K	0.00%	32.96K	$50.10K
Group one trading	6.59K	-	6.59K	$8.63M

Sold Out

Holder	Change
Royal bank of canada	-275.00
Qube research	-299.00
National bank of canada /fi/	-435.00
Lazard asset management	-594.00
Entrypoint capital	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	51	4.08%	27,751,924	7.80%	64	1.77%	19	-	10	-33.33%
Mar 31, 2025	51	-5.56%	29,511,633	-3.64%	69	1.33%	20	-	16	-15.79%
Dec 31, 2024	24	-57.89%	6,082,941	-81.22%	14	0.25%	9	-52.63%	7	-61.11%
Sep 30, 2024	57	-10.94%	32,384,039	-4.15%	76	1.19%	19	-26.92%	18	-
Jun 30, 2024	64	-13.51%	33,787,658	-4.85%	80	1.13%	26	23.81%	18	-30.77%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Genomic Revolution ETF	1.13M	2.65%	-1.65K
ARK Genomic Revolution	1.10M	2.59%	-872.23K
Nikko Gbl All Biological Genome Eq MF	297.64K	0.70%	-28.36K
A4Investments SICAV SIF ACCI IlanaA2EURH	160.00K	0.38%	-
Northern Small Cap Core I	86.94K	0.20%	-5.12K
Vanguard Health Care ETF	52.52K	0.12%	231.00
Biotech Growth Ord	49.26K	0.11%	-
Range Cancer Therapeutics ETF	47.41K	0.11%	-
NT Quality SCC US Fund - L	43.72K	0.10%	-3.48K
NT Quality Small Cap Core	43.72K	0.10%	-3.48K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2025	Koehler Maria	EVP, CHIEF MEDICAL OFFICER	Sell	$4.10K
Mar 12, 2025	Zinda Michael	EVP, CHIEF SCIENTIFIC OFFICER	Sell	$6.40K
Mar 12, 2025	Forte Steve	EVP, CHIEF FINANCIAL OFFICER	Sell	$7.85K
Mar 12, 2025	Segal Lloyd Mitchell	PRESIDENT AND CEO	Sell	$24.14K
Mar 28, 2024	Segal Lloyd Mitchell	PRESIDENT AND CEO	Sell	$12.24K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	4
2024 Q2	-	4
2024 Q1	-	16
2023 Q4	9	-
2023 Q2	-	3

RPTX Ownership FAQ

Who Owns Repare Therapeutics?

Repare Therapeutics shareholders are primarily institutional investors at 64.66%, followed by 1.25% insiders and 34.09% retail investors. The average institutional ownership in Repare Therapeutics's industry, Biotech Stocks , is 304.14%, which Repare Therapeutics falls below.

Who owns the most shares of Repare Therapeutics?

Repare Therapeutics’s largest shareholders are Bvf inc/il (10.33M shares, 24.08%), Blue owl capital lp (3.44M shares, 8.02%), and Orbimed advisors (3.32M shares, 7.74%). Together, they hold 39.84% of Repare Therapeutics’s total shares outstanding.

Does Blackrock own Repare Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Repare Therapeutics.

Who is Repare Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Repare Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.48% of its assets in 2.65M Repare Therapeutics shares, valued at 3.68M$.

Who is the top mutual fund holder of Repare Therapeutics shares?

ARK Genomic Revolution ETF is the top mutual fund holder of Repare Therapeutics shares, with 2.65% of its total shares outstanding invested in 1.13M Repare Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools